Literature DB >> 11849854

The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?

Luis Gruberg1, Neil J Weissman, Ron Waksman, Shmuel Fuchs, Regina Deible, Ellen E Pinnow, Lanja M Ahmed, Kenneth M Kent, Augusto D Pichard, William O Suddath, Lowell F Satler, Joseph Lindsay.   

Abstract

OBJECTIVES: The purpose of this study was to assess the impact of body mass index (BMI) on the short- and long-term outcomes after percutaneous coronary intervention (PCI).
BACKGROUND: Obesity is associated with advanced coronary artery disease (CAD). However, the relation between BMI and outcome after PCI remains controversial.
METHODS: We studied 9,633 consecutive patients who underwent PCI between January 1994 and December 1999. Patients were divided into three groups according to BMI: normal, BMI between 18.5 and 24.9 (n = 1,923); overweight, BMI between 25 and 30 (n = 4,813); and obese, BMI >30 (n = 2,897).
RESULTS: Obese patients were significantly younger and had consistently worse baseline clinical characteristics than normal or overweight patients, with a higher incidence of hypertension, diabetes, hypercholesterolemia and smoking history (p < 0.0001). Despite similar angiographic success rates among the three groups, normal BMI patients had a higher incidence of major in-hospital complications, including cardiac death (p = 0.001). At one-year follow-up, overall mortality rates were significantly higher for normal BMI patients compared with overweight or obese patients (p < 0.0001). Myocardial infarction and revascularization rates did not differ among the three groups. By multivariate Cox regression analysis, diabetes, hypertension, age, BMI and left ventricular function were independent predictors of long-term mortality.
CONCLUSIONS: In patients with known CAD who undergo PCI, very lean patients (BMI <18.5) and those with BMI within the normal range are at the highest risk for in-hospital complications and cardiac death and for increased one-year mortality.

Entities:  

Mesh:

Year:  2002        PMID: 11849854     DOI: 10.1016/s0735-1097(01)01802-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  152 in total

1.  Visceral fat area, not body mass index, predicts postoperative 30-day morbidity in patients undergoing colon resection for cancer.

Authors:  Benjamin A Kuritzkes; Emmanouil P Pappou; Ravi P Kiran; Onur Baser; Liqiong Fan; Xiaotao Guo; Binsheng Zhao; Stuart Bentley-Hibbert
Journal:  Int J Colorectal Dis       Date:  2018-04-15       Impact factor: 2.571

2.  Impact of body mass index on clinical outcome in patients with acute coronary syndromes treated with percutaneous coronary intervention.

Authors:  Gjin Ndrepepa; Dritan Keta; Robert A Byrne; Stefanie Schulz; Julinda Mehilli; Melchior Seyfarth; Albert Schömig; Adnan Kastrati
Journal:  Heart Vessels       Date:  2010-01-21       Impact factor: 2.037

3.  Obesity paradox in the era of percutaneous coronary intervention with 2nd-generation drug-eluting stents: an analysis of a multicenter PCI registry.

Authors:  Daisuke Ueshima; Shunji Yoshikawa; Taro Sasaoka; Yu Hatano; Ken Kurihara; Yasuhiro Maejima; Mitsuaki Isobe; Takashi Ashikaga
Journal:  Heart Vessels       Date:  2018-07-31       Impact factor: 2.037

4.  Visceral obesity and colorectal cancer: are we missing the boat with BMI?

Authors:  Aaron S Rickles; James C Iannuzzi; Oleg Mironov; Andrew-Paul Deeb; Abhiram Sharma; Fergal J Fleming; John R T Monson
Journal:  J Gastrointest Surg       Date:  2012-10-23       Impact factor: 3.452

5.  Weight change after antiretroviral therapy and mortality.

Authors:  Bianca Yuh; Janet Tate; Adeel A Butt; Kristina Crothers; Matthew Freiberg; David Leaf; Mary Logeais; David Rimland; Maria C Rodriguez-Barradas; Christopher Ruser; Amy C Justice
Journal:  Clin Infect Dis       Date:  2015-03-11       Impact factor: 9.079

Review 6.  Critical appraisal of the obesity paradox in cardiovascular disease: how to manage patients with overweight in heart failure?

Authors:  Wolfram Doehner
Journal:  Heart Fail Rev       Date:  2014-09       Impact factor: 4.214

7.  Feasibility of bariatric surgery as a strategy for secondary prevention in cardiovascular disease: a report from the Swedish obese subjects trial.

Authors:  Lotta Delling; Kristjan Karason; Torsten Olbers; David Sjöström; Björn Wahlstrand; Björn Carlsson; Lena Carlsson; Kristina Narbro; Jan Karlsson; Carl Johan Behre; Lars Sjöström; Kaj Stenlöf
Journal:  J Obes       Date:  2010-08-12

Review 8.  Body weight and mortality in COPD: focus on the obesity paradox.

Authors:  Francesco Spelta; A M Fratta Pasini; L Cazzoletti; M Ferrari
Journal:  Eat Weight Disord       Date:  2017-11-06       Impact factor: 4.652

9.  Weight change after myocardial infarction--the Enhancing Recovery in Coronary Heart Disease patients (ENRICHD) experience.

Authors:  Francisco Lopez-Jimenez; Colin O Wu; Xin Tian; Chris O'Connor; Michael W Rich; Matthew M Burg; David Sheps; James Raczynski; Virend K Somers; Allan S Jaffe
Journal:  Am Heart J       Date:  2008-01-15       Impact factor: 4.749

10.  Social deprivation and prognostic benefits of cardiac surgery: observational study of 44 902 patients from five hospitals over 10 years.

Authors:  D Pagano; N Freemantle; B Bridgewater; N Howell; D Ray; M Jackson; B M Fabri; J Au; D Keenan; B Kirkup; B E Keogh
Journal:  BMJ       Date:  2009-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.